Technical Analysis for BIMUF - Pascal Biosciences Inc

Grade Last Price % Change Price Change
grade C 0.13 8.33% 0.0100
BIMUF closed up 8.33 percent on Friday, September 18, 2020, on 3 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down
Historical BIMUF trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish 8.33%
Narrow Range Bar Range Contraction 8.33%
Wide Bands Range Expansion 8.33%
Gapped Down Weakness 8.33%
Oversold Stochastic Weakness 8.33%
Older End-of-Day Gignals for BIMUF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Pascal Biosciences Inc., a drug discovery and development company, researches and develops biotechnology products for the treatment of cancer and for the enhancement of immune system in Canada. Its research programs include the development of Anti-VpreB, a therapeutic monoclonal antibody for treatment of B-cell precursor acute lymphoblastic leukemia in collaboration with the University of New Mexico; optimization of novel classes of molecules that restore immune recognition and killing of cancer cells; and regulating activity of immune system calcium channels to combat cancers, infections, and autoimmune diseases. The company has a collaboration agreement with the University of British Columbia. Pascal Biosciences Inc. is headquartered in Vancouver, Canada.
Medicine Medical Specialties Cancer Drug Discovery Immunology Treatment Of Cancer Autoimmune Diseases Cancers Immune System Cancer Immunotherapy Monoclonal Antibody Infections Biotechnology Products Acute Lymphoblastic Leukemia

Is BIMUF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 0.6611
52 Week Low 0.0539
Average Volume 9,596
200-Day Moving Average 0.2213
50-Day Moving Average 0.1218
20-Day Moving Average 0.1673
10-Day Moving Average 0.1343
Average True Range 0.0172
ADX 21.56
+DI 46.2020
-DI 41.4858
Chandelier Exit (Long, 3 ATRs ) 0.2384
Chandelier Exit (Short, 3 ATRs ) 0.1679
Upper Bollinger Band 0.2424
Lower Bollinger Band 0.0922
Percent B (%b) 0.25
BandWidth 89.7788
MACD Line -0.0031
MACD Signal Line 0.0047
MACD Histogram -0.0077
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1300
Resistance 3 (R3) 0.1300 0.1300 0.1300
Resistance 2 (R2) 0.1300 0.1300 0.1300 0.1300
Resistance 1 (R1) 0.1300 0.1300 0.1300 0.1300 0.1300
Pivot Point 0.1300 0.1300 0.1300 0.1300 0.1300
Support 1 (S1) 0.1300 0.1300 0.1300 0.1300 0.1300
Support 2 (S2) 0.1300 0.1300 0.1300 0.1300
Support 3 (S3) 0.1300 0.1300 0.1300
Support 4 (S4) 0.1300